Document is current
Any future updates will be listed below
-
Authors
Garcha, Damanpreet
Walker, Susan P.
MacDonald, Teresa M.
Hyett, Jon
Jellins, Jessica
Myers, Jenny
Illanes, Sebastian E.
Nien, Jhy K.
Schepeler, Manuel
Keenan, Emerson
Whigham, Carole-Anne
Cannon, Ping
Murray, Elizabeth
Nguyen, Tuong-Vi
Kandel, Manju
Masci, Joshua
Murphy, Ciara
Cruickshank, Tess
Pritchard, Natasha
Hannan, Natalie J.
Brownfoot, Fiona
Roddy Mitchell, Alexandra
Middleton, Anna
Pell, Gabrielle
Wong, Georgia P.
Tong, Stephen
Kaitu’u-Lino, Tu’uhevaha J.
-
Funding
Funding for this research was provided by:
National Health and Medical Research Council (#1065854)
National Health and Medical Research Council (#1183854)
National Health and Medical Research Council (#116071)
National Health and Medical Research Council (#1146128)
National Health and Medical Research Council (#1159261)
RANZCOG
- License Information
-
More Information
Article History
Received: 7 June 2021
Accepted: 30 July 2021
First Online: 16 August 2021
Competing interests
: TKL, TM, SW and ST hold a provisional patent (PCT/AU2019/050516) relating to the use of SPINT1 and syndecan-1 as diagnostic markers in pregnancy. The remaining authors have no conflicts of interest to declare.
